Interleukin-1 beta is significantly upregulated in the decidua of spontaneous and recurrent miscarriage placentas.


Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
04 2021
Historique:
received: 18 09 2020
revised: 07 01 2021
accepted: 26 01 2021
pubmed: 6 2 2021
medline: 6 11 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

Pregnancy is an extraordinarily complex immunological process. For successful pregnancy maintenance the maternal immune system must adapt to and tolerate the semi-allogenic fetus at the fetomaternal interface of the placenta. This balance is regulated by cytokines with a predominant T helper 2 (Th-2) system and a suppressed inflammatory T helper 1 (Th-1) response. This study investigates the role of the Th-1 pro-inflammatory cytokine Interleukin-1 beta (IL-1β) and its role in early pregnancy loss. In order to identify differences in IL- β levels a TaqMan® Human Cytokine Network Array, with placental tissue obtained from patients with healthy pregnancies (n = 15) and recurrent miscarriage (n = 15), was carried out. Protein expression of IL-1β in the decidua of healthy pregnancies (n = 15), spontaneous (n = 18) and recurrent miscarriages (n = 15), was investigated by immunohistochemistry. The identification of IL-1β expressing cells in the decidua was done with double-immunofluorescence. Gene expression analysis identified a nearly 54-times higher expression of IL-1β in placental tissue of patients suffering from recurrent abortion. Immunohistochemistry confirmed a significant upregulation of IL-1β in the decidua of recurrent miscarriage specimens (p = 0.01) as well as in the decidua of women with spontaneous abortion (p = 0.001). Double-immunofluorescence identified decidual stoma cells as IL-1β expressing cells. Significant upregulation of IL-1β may be associated with an imbalanced immune system and a procoagulant state that could be responsible for early pregnancy loss. These results provide new evidence of the complex interplay of IL-1β at the fetomaternal interface and its crucial role in miscarriage processes.

Sections du résumé

BACKGROUND
Pregnancy is an extraordinarily complex immunological process. For successful pregnancy maintenance the maternal immune system must adapt to and tolerate the semi-allogenic fetus at the fetomaternal interface of the placenta. This balance is regulated by cytokines with a predominant T helper 2 (Th-2) system and a suppressed inflammatory T helper 1 (Th-1) response. This study investigates the role of the Th-1 pro-inflammatory cytokine Interleukin-1 beta (IL-1β) and its role in early pregnancy loss.
PATIENTS AND METHODS
In order to identify differences in IL- β levels a TaqMan® Human Cytokine Network Array, with placental tissue obtained from patients with healthy pregnancies (n = 15) and recurrent miscarriage (n = 15), was carried out. Protein expression of IL-1β in the decidua of healthy pregnancies (n = 15), spontaneous (n = 18) and recurrent miscarriages (n = 15), was investigated by immunohistochemistry. The identification of IL-1β expressing cells in the decidua was done with double-immunofluorescence.
RESULTS
Gene expression analysis identified a nearly 54-times higher expression of IL-1β in placental tissue of patients suffering from recurrent abortion. Immunohistochemistry confirmed a significant upregulation of IL-1β in the decidua of recurrent miscarriage specimens (p = 0.01) as well as in the decidua of women with spontaneous abortion (p = 0.001). Double-immunofluorescence identified decidual stoma cells as IL-1β expressing cells.
CONCLUSION
Significant upregulation of IL-1β may be associated with an imbalanced immune system and a procoagulant state that could be responsible for early pregnancy loss. These results provide new evidence of the complex interplay of IL-1β at the fetomaternal interface and its crucial role in miscarriage processes.

Identifiants

pubmed: 33545613
pii: S0165-0378(21)00013-9
doi: 10.1016/j.jri.2021.103283
pii:
doi:

Substances chimiques

IL1B protein, human 0
Interleukin-1beta 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103283

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Sanja Löb (S)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany; Department of Obstetrics and Gynecology, University Hospital, University of Wuerzburg, Germany.

Niklas Amann (N)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Christina Kuhn (C)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany; Department of Obstetrics and Gynecology, University Hospital Augsburg, Germany.

Elisa Schmoeckel (E)

Department of Pathology, University Hospital, LMU Munich, Germany.

Achim Wöckel (A)

Department of Obstetrics and Gynecology, University Hospital, University of Wuerzburg, Germany.

Alaleh Zati Zehni (A)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Till Kaltofen (T)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Simon Keckstein (S)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Jan-Niclas Mumm (JN)

Department of Urology, University Hospital, LMU Munich, Germany.

Sarah Meister (S)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Thomas Kolben (T)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Sven Mahner (S)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Udo Jeschke (U)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany; Department of Obstetrics and Gynecology, University Hospital Augsburg, Germany. Electronic address: udo.jeschke@med.uni-muenchen.de.

Theresa Vilsmaier (T)

Department of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH